Cargando…

Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease

Neutrophils and platelets are among the most abundant cell types in peripheral blood and characterized by high plasticity and a readily available reservoir of surface proteins and secretable granule contents. Receptor-mediated activation and granule release predispose both cell types for rapid respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaiser, Rainer, Escaig, Raphael, Erber, Johanna, Nicolai, Leo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841491/ https://www.ncbi.nlm.nih.gov/pubmed/35174225 http://dx.doi.org/10.3389/fcvm.2021.824112

Ejemplares similares

Platelet-Derived Microvesicles in Cardiovascular Diseases
por: Zaldivia, Maria T. K., et al.
Publicado: (2017)

Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection
por: Zucoloto, Amanda Z., et al.
Publicado: (2019)

The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment
por: Hu, Huilin, et al.
Publicado: (2021)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

Targeting Lipid—Ion Channel Interactions in Cardiovascular Disease
por: Hudgins, Emma C., et al.
Publicado: (2022)

Editorial: Role of the Platelet Phenomenon in Cardiovascular Diseases and Cancer
por: Panova-Noeva, Marina, et al.
Publicado: (2022)

Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
por: Baidildinova, Gaukhar, et al.
Publicado: (2021)

Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity
por: Fors, Martha, et al.
Publicado: (2022)

Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease
por: Pennings, Gabrielle J., et al.
Publicado: (2023)

Platelets Are at the Nexus of Vascular Diseases
por: Lebas, Héloïse, et al.
Publicado: (2019)

Gut immune cells—A novel therapeutical target for cardiovascular disease?
por: Ganesh, Naresh, et al.
Publicado: (2022)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Editorial: Established and Novel Roles of Platelets in Health and Disease
por: Jurasz, Paul, et al.
Publicado: (2022)

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
por: Hua, Cun-Cun, et al.
Publicado: (2022)

Single platelet and megakaryocyte morpho-dynamics uncovered by multicolor reporter mouse strains in vitro and in vivo
por: Nicolai, Leo, et al.
Publicado: (2021)

Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy
por: Xie, Yixin, et al.
Publicado: (2023)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Midkine—A novel player in cardiovascular diseases
por: Majaj, Marina, et al.
Publicado: (2022)

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
por: Lin, Xiao, et al.
Publicado: (2022)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Using RNA-based therapies to target the kidney in cardiovascular disease
por: Palmer, Trecia C., et al.
Publicado: (2023)

A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™
por: Iversen, Patrick L., et al.
Publicado: (2023)

Platelet Membrane Receptor Proteolysis: Implications for Platelet Function
por: Wu, Jiayu, et al.
Publicado: (2021)

Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis
por: Yao, Yao, et al.
Publicado: (2022)

The Innate Immune cGAS-STING-Pathway in Cardiovascular Diseases – A Mini Review
por: Rech, Lavinia, et al.
Publicado: (2021)

Genetic and Cellular Interaction During Cardiovascular Development Implicated in Congenital Heart Diseases
por: Kodo, Kazuki, et al.
Publicado: (2021)

Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
por: Bartoloni, Elena, et al.
Publicado: (2018)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
por: Tintut, Yin, et al.
Publicado: (2018)

Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases
por: Cai, Yang-Wei, et al.
Publicado: (2023)

Editorial: Receptors in cardiovascular diseases: Mechanisms, diagnosis, and treatment
por: Shen, Shutong, et al.
Publicado: (2023)

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer
por: Nebigil, Canan G., et al.
Publicado: (2023)

Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation
por: Kaldirim, Madlen, et al.
Publicado: (2022)

Platelet Function in Aging
por: Le Blanc, Jessica, et al.
Publicado: (2019)

Turning Platelets Off and On: Role of RhoGAPs and RhoGEFs in Platelet Activity
por: Comer, Shane P.
Publicado: (2022)

A Novel Dried Blood Spot Detection Strategy for Characterizing Cardiovascular Diseases
por: Liu, Linsheng, et al.
Publicado: (2020)

Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
por: AlZaim, Ibrahim, et al.
Publicado: (2020)

AAV-mediated gene therapy: Advancing cardiovascular disease treatment
por: Zhang, Huili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6hp8qlu7sdraf1v8hca5rcb48o